蛋白氨酸酸酶PRL-3:癌症信号传递中的一个关键参与者
Haidong Liu1,2, Xiao Li3, Yin Shi4
1Zhejiang Cancer Hospital, Hangzhou 310022, China.
Biomolecules
|March 28, 2024
概括
肝脏-3再生酸酶 (PRL-3) 是癌症进展中的关键酸酶,影响多个细胞过程. 研究正在推进有针对性的疗法,包括小分子抑制剂和抗体,以有效治疗癌症.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 蛋白质酸酶通过脱化调节信号传导.
- 再生性肝脏-3酸酶 (PRL-3) 是一种与癌症发展相关的双特异性酸酶.
- 针对PRL-3对于新型癌症疗法至关重要.
研究的目的:
- 审查PRL-3的调节机制,表达和癌症中的作用.
- 总结PRL-3在扩散,迁移,入侵,转移,血管生成和耐药性的参与.
- 讨论治疗抑制剂的进展情况和PRL-3的预后价值.
主要方法:
- 对PRL-3在癌症中的功能进行文献综述.
- 监管机制的分析,包括转录控制,替代拼接和翻译后修改.
- 在各种癌症类型中评估PRL-3的表达模式.
主要成果:
- 通过多种细胞功能,PRL-3显著促进癌症的进展.
- 在某些癌症中,PRL-3的特定表达模式表明了治疗潜力.
- 小分子抑制剂和抗体PRL-3-zumab在临床前和临床研究中显示出有希望的结果.
结论:
- 由于其多方面的作用,PRL-3是癌症治疗的关键目标.
- 需要进一步的研究来优化PRL-3抑制剂的临床应用.
- 在正在进行的临床试验中,prl-3-zumab代表了一个有前途的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


